• English


Undergraduate Degree

  • Carleton College , 2004 , Northfield , MN

Graduate Degree

  • University of Wisconsin-Madison , 2008 , Madison , WI

Medical School

  • Medical College of Wisconsin , 2012 , Milwaukee , WI


  • Boston Combined Residency Program (BCRP) , 2015 , Boston , MA


  • Harvard Medical Toxicology Program , 2017 , Boston , MA


Pediatric Emergency Medicine Fellowship
  • Boston Children's Hospital , 2019 , Boston , MA


Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center.


  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Medical Toxicology


Publications powered by Harvard Catalyst Profiles

  1. COVID-19 and Pediatric Ingestions. Pediatrics. 2021 07; 148(1). View abstract
  2. Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives. Addiction. 2021 06; 116(6):1512-1513. View abstract
  3. Clinical Effects of Pediatric Clonidine Exposure: A Retrospective Cohort Study at a Single Tertiary Care Center. J Emerg Med. 2021 Jan; 60(1):58-66. View abstract
  4. Association of State-Level Opioid-Reduction Policies With Pediatric Opioid Poisoning. JAMA Pediatr. 2020 10 01; 174(10):961-968. View abstract
  5. Neonate With Abdominal Distention. Ann Emerg Med. 2019 Apr; 73(4):e41-e42. View abstract
  6. Case 1: A Medically Complex 10-month-old Boy with Lethargy. Pediatr Rev. 2019 Feb; 40(2):79-81. View abstract
  7. Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism. Br J Clin Pharmacol. 2019 01; 85(1):258-262. View abstract
  8. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity. J Med Toxicol. 2018 12; 14(4):306-322. View abstract
  9. Myocardial Infarct After Marijuana Inhalation in a 16-year-old Adolescent Boy. Pediatr Dev Pathol. 2019 Jan-Feb; 22(1):80-86. View abstract
  10. Acute Amnestic Syndrome Associated with Fentanyl Overdose. N Engl J Med. 2018 Mar 22; 378(12):1157-1158. View abstract
  11. A case report of methadone-associated hypoglycemia in an 11-month-old male. Clin Toxicol (Phila). 2018 01; 56(1):74-76. View abstract
  12. The Poisoned Pediatric Patient. Pediatr Rev. 2017 May; 38(5):207-220. View abstract
  13. A Case Report of Reversible Takotsubo Cardiomyopathy after Amphetamine/Dextroamphetamine Ingestion in a 15-Year-Old Adolescent Girl. J Pediatr. 2017 03; 182:385-388.e3. View abstract
  14. Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center. Clin Toxicol (Phila). 2017 Jan; 55(1):12-17. View abstract